Association of cellular apoptosis with anti-tumor effects of the Chinese herbal complex in endocrine-resistant cancer cell line

Cancer Detection and Prevention

Volumn 27, Issue 2, 2003, Pages 147-154

  Lian, Zenglin ^a   Niwa, Kenji ^a   Gao, Jingchun ^a   Tagami, Keiko ^a   Mori, Hideki ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; bcl 2; c myc; Endocrine resistant; Herbal medicine; hTERT

Indexed keywords

EID: 0037254614     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(03)00026-6     Document Type: Article

References (30)

1. Yasukawa K, Yu SY, Kakinuma S, et al. Inhibitory effect of rikkunshi-to, a traditional Chinese herbal prescription, on tumor promotion in two-stage carcinogenesis in mouse skin. Biol Pharm Bull 1995;18:730-3.
2. Aburada M, Takeda S, Itoh E, et al. Protective effects of juzentaihoto, dried decoctum of 10 Chinese herbs mixture, upon the adverse effects of mitomycin C in mice. J Pharmacobiodyn 1983;6:1000-4.
3. Yamada H, Kiyohara H, Cyong JC, et al. Studies on polysaccharides from Angelica acutiloba. Part 1. Fraction and biological properties of polysaccharides. Planta Med 1984;50:163-7.
4. Ikemoto S, Sugimura K, Yoshida N, et al. Anti-tumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 2000;55:951-5.
5. Ishiwata S, Nakashita K, Ozawa Y, et al. Fas-mediated apoptosis is enhanced by glycyrrhizin without alteration of caspase-3-like activity. Biol Pharm Bull 1999;22:1163-6.
6. Oh C, Kim Y, Eun J, et al. Induction of T-lymphocyte apoptosis by treatment with glycyrrhizin. Am J Chin Med 1999;27:217-26.
7. Chan FL, Choi HL, Chen ZY, et al. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett 2000;160:219-28.
8. Matsuzaki Y, Kurokawa N, Terai S, et al. Cell death induced by baicalein in human hepatocellular carcinoma cell lines. Jpn J Cancer Res 1996;87:170-7.
9. Niwa K, Hashimoto M, Morishita S, et al. Preventive effects of Glycyrrhizae radix extract on estrogen-related endometrial carcinogenesis in mice. Jpn J Cancer Res 1999;90:726-32.
10. Lian Z, Fujimoto J, Yokoyama Y, et al. Herbal complex suppresses telomerase activity in chemo-endocrine-resistant cancer cell lines. Eur J Gynaecol Oncol 2001;22:347-9.
11. Sugiyama K, Ueda H, Ichio Y. Protective effects of Juzen-taiho-to against carboplatin-induced toxic side effects in mice. Biol Pharm Bull 1995;18:544-8.
12. Ohnishi Y, Yasumizu R, Fan HX, et al. Effects of Juzen-taiho-to (TJ-48), a traditional oriental medicine, on hematopoietic recovery from radiation injury in mice. Exp Hematol 1990;18:18-22.
13. Maruyama H, Takemoto N, Maruyama N, et al. Anti-tumor effect of Juzen-taiho-to, a Kampo medicine, combined with surgical excision of transplanted Meth-fibrosarcoma. Int J Immunother 1993;9:117-25.
14. Sakai I. A Kampo medicine "Juzen-taiho-to" - prevention of malignant progression and metastasis of tumor cells and the mechanism of action. Biol Pharm Bull 2000;23:677-88.
15. Niwa K, Hashimoto M, Morishita S, et al. Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17β-induced endometrial carcinogenesis in mice. Carcinogenesis 2001;22:587-91.
16. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
17. Yokoyama Y, Takahashi Y, Shinohara A, et al. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol 1998;68:145-9.
18. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-9.
19. Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998;58:1558-61.
20. Latil A, Vidaud D, Valeri A, et al. hTERT expression correlates with myc over-expression in human prostate cancer. Int J Cancer 2000;89:172-6.
21. Huang Y, Ray S, Reed JC, et al. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF7 cells. Breast Cancer Res Treat 1997;42:73-81.
22. Iida A, Yamaguchi A, Hirose K, et al. Telomerase activity in colorectal cancer and its relationship to bcl-2 expression. J Surg Oncol 2000;73:219-23.
23. Yokoyama Y, Takahashi Y, Shinohara A, et al. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cell. Cancer Res 1998;58:5406-10.
24. Mosmann T, et al. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
25. Waterhouse N, Kumar S, Song Q, et al. Heteronuclear ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of interleukin-1β converting enzyme-like proteases in apoptosis. J Biol Chem 1996;271:29335-41.
26. Gunes C, Lichtsteiner S, Vasserot AP, et al. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 2000;60:2116-21.
27. Wang J, Liu X, Jiang W, et al. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis. Chin Med J (Engl) 2000;113:985-90.
28. Lyu SY, Choi SH, Park WB, et al. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch Pharm Res 2002;25:93-101.
29. Ji ZN, Ye WC, Liu GQ, et al. Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells. Planta Med 2002;68:596-600.
30. Lian Z, Niwa K, Gao J, et al. Shimotsu-to is the agent in Juzen-taiho-to responsible for the prevention of endometrial carcinogenesis in mice. Cancer Lett 2002;182:19-26.